SlideShare a Scribd company logo
1 of 57
© 2015 Pearson Education, Inc.
Chapter 10
© 2015 Pearson Education, Inc.
The History of Antimicrobial Agents
• Drugs
• Chemicals that affect physiology in any manner
• Chemotherapeutic agents
• Drugs that act against diseases
• Antimicrobial agents
• Drugs that treat infections
© 2015 Pearson Education, Inc.
The History of Antimicrobial Agents
• Paul Ehrlich
• "Magic bullets"
• Arsenic compounds that killed microbes
• Alexander Fleming
• Penicillin released from Penicillium
• Gerhard Domagk
• Discovered sulfanilamide
• Selman Waksman
• Antibiotics
• Antimicrobial agents produced naturally by organisms
© 2015 Pearson Education, Inc.
Figure 10.1 Antibiotic effect of the mold Penicillium chrysogenum.
Staphylococcus
aureus
(bacterium)
Zone where
bacterial growth
is inhibited
Penicillium
chrysogenum
(fungus)
© 2015 Pearson Education, Inc.
The History of Antimicrobial Agents
• Semisynthetics
• Chemically altered antibiotics that are more effective,
longer lasting, or easier to administer than naturally
occurring ones
• Synthetics
• Antimicrobials that are completely synthesized in a lab
© 2015 Pearson Education, Inc.
© 2015 Pearson Education, Inc.
The History of Antimicrobial Agents
• Tell Me Why
• Why aren't antibiotics effective against the common
cold?
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Successful chemotherapy requires selective
toxicity
• Antibacterial drugs constitute largest number and
diversity of antimicrobial agents
• Fewer drugs to treat eukaryotic infections
• Antiviral drugs limited
© 2015 Pearson Education, Inc.
Figure 10.2 Mechanisms of action of microbial drugs.
Inhibition of cell
wall synthesis
Penicillins
Carbapenems
Cephalosporins
Vancomycin
Bacitracin
Isoniazid
Ethambutol
Echinocandins
(antifungal)Inhibition of pathogen’s
attachment or entry
into host cell
Arildone
Pleconaril
Enfuvirtide
Human
cell membrane
Inhibition of DNA
or RNA synthesis
Actinomycin
Nucleotide
analogs
Quinolones
Rifampin
Inhibition of general
metabolic pathway
Sulfonamides
Trimethoprim
Dapsone
Disruption of
cytoplasmic membrane
Polymyxins
Polyenes (antifungal)
Inhibition of
protein synthesis
Aminoglycosides
Tetracyclines
Chloramphenicol
Macrolides
Antisense nucleic acids
© 2015 Pearson Education, Inc.
Chemotherapeutic Agents: Modes of Action
© 2015 Pearson Education, Inc.
Figure 10.3a-b Bacterial cell wall synthesis and the inhibitory effects of beta-lactams on it.
NAG
NAM
NAG-NAM
chain
Crossbridge
between NAM
and NAM
New NAG and NAM subunits
Growth
A bacterial cell wall is made of peptidoglycan,
which is made of NAG-NAM chains that are
cross-linked by peptide bridges between the NAM
subunits.
New NAG and NAM subunits are inserted into the wall by enzymes,
allowing the cell to grow. Other enzymes link new NAM subunits to
old NAM subunits with peptide cross-links.
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Cell Wall Synthesis
• Inhibition of synthesis of bacterial walls
• Most common agents prevent cross-linkage of NAM
subunits
• Beta-lactams are most prominent in this group
• Functional groups are beta-lactam rings
• Beta-lactams bind to enzymes that cross-link NAM
subunits
• Bacteria have weakened cell walls and eventually lyse
© 2015 Pearson Education, Inc.
Figure 10.3c-e Bacterial cell wall synthesis and the inhibitory effects of beta-lactams on it.
New cross-links
inhibited by
beta-lactam
Previously
formed
cross-link
Penicillins
Methicillin (semisynthetic)
Carbapenems
Imipenem (semisynthetic)
Growth
Beta-lactam interferes with the linking enzymes, and NAM
subunits remain unattached to their neighbors. However,
the cell continues to grow as it adds more NAG and NAM
subunits.
The cell bursts from osmotic pressure
because the integrity of peptidoglycan is not
maintained.
β-lactam ring
Penicillin G (natural)
Cephalosporins
Cephalothin (natural)
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Cell Wall Synthesis
• Inhibition of synthesis of bacterial walls
• Semisynthetic derivatives of beta-lactams
• More stable in acidic environments
• More readily absorbed
• Less susceptible to deactivation
• More active against more types of bacteria
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Cell Wall Synthesis
• Inhibition of synthesis of bacterial walls
• Vancomycin and cycloserine
• Interfere with particular bridges that link NAM subunits
in many Gram-positive bacteria
• Bacitracin
• Blocks transport of NAG and NAM from cytoplasm
• Isoniazid and ethambutol
• Disrupt mycolic acid formation in mycobacterial
species
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Cell Wall Synthesis
• Inhibition of synthesis of bacterial walls
• Prevent bacteria from increasing amount of peptidoglycan
• Have no effect on existing peptidoglycan layer
• Effective only for growing cells
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Cell Wall Synthesis
• Inhibition of synthesis of fungal walls
• Fungal cells are composed of various polysaccharides not
found in mammalian cells
• Echinocandins inhibit the enzyme that synthesizes glucan
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Protein Synthesis
• Prokaryotic ribosomes are 70S (30S and 50S)
• Eukaryotic ribosomes are 80S (40S and 60S)
• Drugs can selectively target translation
• Mitochondria of animals and humans contain 70S
ribosomes
• Can be harmful
© 2015 Pearson Education, Inc.
Figure 10.4 The mechanisms by which antimicrobials target prokaryotic ribosomes to inhibit protein synthesis.
Incorrect
amino acids
Ribosome
30S Some aminoglycosides, for
example streptomycin, cause
change in 30S shape, so
mRNA is misread.
50S
Amino acids Chloramphenicol blocks
peptide bond formation.
50S
Tetracycline and some
aminoglycosides block
docking site of tRNA.
mRNA
Lincosamides or
macrolides bind
to 50S subunit,
blocking proper
mRNA movement
through ribosome.
Synthesis stops.
fMet
Antisense
nucleic acid
Oxazolidinone30S
mRNA
mRNA
mRNA
mRNA
mRNA
50S
50S
50S
30S
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Disruption of Cytoplasmic Membranes
• Some drugs form channel through cytoplasmic
membrane and damage its integrity
• Amphotericin B attaches to ergosterol in fungal
membranes
• Humans somewhat susceptible because cholesterol is
similar to ergosterol
• Bacteria lack sterols; not susceptible
© 2015 Pearson Education, Inc.
Figure 10.5 Disruption of the cytoplasmic membrane by the antifungal amphotericin B.
Amphotericin B
Phospholipid
Amphotericin B
Ergosterol
Pore
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Disruption of Cytoplasmic Membranes
• Azoles and allylamines inhibit ergosterol synthesis
• Polymyxin disrupts cytoplasmic membranes of
Gram-negative bacteria
• Toxic to human kidneys
• Pyrazinamide only disrupts transport across the
cytoplasmic membrane of Mycobacterium tuberculosis
• Some antiparasitic drugs act against cytoplasmic
membranes
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Metabolic Pathways
• Antimetabolic agents can be effective when pathogen
and host metabolic processes differ
• Atovaquone interferes with electron transport in
protozoa and fungi
• Heavy metals inactivate enzymes
• Agents that disrupt tubulin polymerization and glucose
uptake by many protozoa and parasitic worms
• Drugs block activation of viruses
• Metabolic antagonists
© 2015 Pearson Education, Inc.
Figure 10.6 The antimetabolic action of sulfonamides in inhibiting nucleic acid synthesis.
PABA Sulfanilamide Sulfamethoxazole Sulfisoxazole
PABA
Enzyme Dihydrofolic
acid
Enzyme Tetrahydrofolic
acid (THF)
Enzymes Purine and
pyrimidine
nucleotides
Enzymes
DNA and RNA
Other
substrates
PABA
Dihydrofolic
acid
Other
substrates
PABA
Dihydrofolic acid
not produced
Enzyme
Active site
Enzyme
Para-aminobenzoic acid (PABA) and its structural analogs, the sulfonamides
Role of PABA in folic acid synthesis in bacteria
and protozoa
Inhibition of folic acid synthesis by sulfonamide
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Metabolic Pathways
• Antiviral agents can target unique aspects of viral
metabolism
• Amantadine, rimantadine, and weak organic bases
prevent viral uncoating
• Protease inhibitors interfere with an enzyme that HIV
needs in its replication cycle
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Nucleic Acid Synthesis
• Several drugs block DNA replication or RNA
transcription
• Drugs often affect both eukaryotic and prokaryotic cells
• Not normally used to treat infections
• Used primarily in research and perhaps to slow cancer
cell replication
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Nucleic Acid Synthesis
• Nucleotide or nucleoside analogs
• Interfere with function of nucleic acids
• Distort shapes of nucleic acid molecules and prevent
further replication, transcription, or translation
• Most often used against viruses
• Effective against rapidly dividing cancer cells
© 2015 Pearson Education, Inc.
Figure 10.7 Nucleosides and some of their antimicrobial analogs.
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Inhibition of Nucleic Acid Synthesis
• Quinolones and fluoroquinolones
• Act against prokaryotic DNA gyrase
• Inhibitors of RNA polymerase
• Reverse transcriptase inhibitors
• Act against an enzyme HIV uses in its replication cycle
• Do not harm people because humans lack reverse
transcriptase
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Prevention of Virus Attachment and Entry
• Attachment antagonists block viral attachment or
receptor proteins
• New area of antimicrobial drug development
© 2015 Pearson Education, Inc.
Mechanisms of Antimicrobial Action
• Tell Me Why
• Some antimicrobial drugs are harmful to humans. Why
can physicians safely use such drugs despite the
potential danger?
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Ideal Antimicrobial Agent
• Readily available
• Inexpensive
• Chemically stable
• Easily administered
• Nontoxic and nonallergenic
• Selectively toxic against wide range of pathogens
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Spectrum of Action
• Number of different pathogens a drug acts against
• Narrow-spectrum: effective against few organisms
• Broad-spectrum: effective against many organisms
• May allow for secondary or superinfections to develop
• Killing of normal flora reduces microbial antagonism
© 2015 Pearson Education, Inc.
Figure 10.8 Spectrum of action for selected antimicrobial agents.
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Effectiveness
• Efficacy of antimicrobials assessed by a variety of tests
• Diffusion susceptibility test
• Minimum inhibitory concentration test
• Minimum bactericidal concentration test
© 2015 Pearson Education, Inc.
Figure 10.9 Zones of inhibition in a diffusion susceptibility (Kirby-Bauer) test.
Bacterial lawn Zone of inhibition
© 2015 Pearson Education, Inc.
Figure 10.10 Minimum inhibitory concentration (MIC) test in test tubes.
Increasing concentration of drug
Turbid wells Clear wells
Increasing concentration of drug
© 2015 Pearson Education, Inc.
Figure 10.11 An Etest, which combines aspects of Kirby-Bauer and MIC tests.
© 2015 Pearson Education, Inc.
Figure 10.12 A minimum bactericidal concentration (MBC) test.
Concentration of antibacterial drug (µg/ml)
Clear
MIC tube
8 μg/ml 16 μg/ml 25 μg/ml
Bacterial colonies No colonies No colonies
Drug-free media
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Routes of Administration
• Topical application of drug for external infections
• Oral route requires no needles and is self-administered
• Intramuscular administration delivers drug via needle
into muscle
• Intravenous administration delivers drug directly to
bloodstream
• Must know how antimicrobial agent will be distributed to
infected tissues
© 2015 Pearson Education, Inc.
Figure 10.13 The effect of route of administration on blood levels of a chemotherapeutic agent.
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Safety and Side Effects
• Toxicity
• Cause of many adverse reactions is poorly understood
• Drugs may be toxic to kidneys, liver, or nerves
• Consideration needed when prescribing drugs to pregnant
women
• Therapeutic index is the ratio of the dose of a drug that
can be tolerated to the drug's effective dose
• Use drug within its therapeutic range
© 2015 Pearson Education, Inc.
Figure 10.14 Some side effects resulting from toxicity of antimicrobial agents.
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Safety and Side Effects
• Allergies
• Allergic reactions are rare but may be life threatening
• Anaphylactic shock
• Disruption of normal microbiota
• May result in secondary infections
• Overgrowth of normal flora, causing superinfections
• Of greatest concern for hospitalized patients
© 2015 Pearson Education, Inc.
Clinical Considerations in Prescribing
Antimicrobial Drugs
• Tell Me Why
• Why don't physicians invariably prescribe the
antimicrobial with the largest zone of inhibition?
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• The Development of Resistance in Populations
• Some pathogens are naturally resistant
• Bacteria acquire resistance in two ways
• New mutations of chromosomal genes
• Acquisition of R plasmids via transformation, transduction,
and conjugation.
© 2015 Pearson Education, Inc.
Figure 10.15 The development of a resistant strain of bacteria.
Sensitive cells inhibited by exposure to drug
Drug-sensitive cells Drug-resistant
mutant
Exposure
to drug
Remaining
population
grows over
time
Population of microbial cells Most cells now resistant
© 2015 Pearson Education, Inc.
Antibiotic Resistance: Origins of Resistance
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• Mechanisms of Resistance
• At least seven mechanisms of microbial resistance exist
• Produce enzyme that destroys or deactivates drug
• Slow or prevent entry of drug into the cell
• Alter target of drug so it binds less effectively
• Alter their own metabolic chemistry
• Pump antimicrobial drug out of the cell before it can act
• Bacteria in biofilms can resist antimicrobials
• Mycobacterium tuberculosis produces MfpA protein
• Binds DNA gyrase, preventing the binding of
fluoroquinolone drugs
© 2015 Pearson Education, Inc.
Figure 10.16 How β-lactamase (penicillinase) renders penicillin inactive.
Lactam ring
Penicillin
β-lactamase (penicillinase)
breaks this bond Inactive penicillin
© 2015 Pearson Education, Inc.
Antibiotic Resistance: Forms of Resistance
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• Multiple Resistance and Cross Resistance
• Pathogen can acquire resistance to more than one drug
• Common when R plasmids exchanged
• Develop in hospitals and nursing homes
• Constant use of drugs eliminates sensitive cells
• Multi-drug-resistant pathogens are resistant to at least
three antimicrobial agents
• Cross resistance to similar drugs may develop
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• Retarding Resistance
• Maintain high concentration of drug in patient for
sufficient time
• Inhibit the pathogen so immune system can eliminate
• Use antimicrobial agents in combination
• Synergism versus antagonism
© 2015 Pearson Education, Inc.
Figure 10.17 An example of synergism between two antimicrobial agents.
Disk with semisynthetic
amoxicillin-clavulanic acid
Disk with semisynthetic
aztreonam
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• Retarding Resistance
• Use antimicrobials only when necessary
• Develop new variations of existing drugs
• Second-generation drugs
• Third-generation drugs
• Search for new antibiotics, semisynthetics, and
synthetics
• Bacteriocins
• Design drugs complementary to the shape of microbial
proteins to inhibit them
© 2015 Pearson Education, Inc.
Resistance to Antimicrobial Drugs
• Tell Me Why
• Why is it incorrect to say that an individual bacterium
develops resistance in response to an antibiotic?
© 2015 Pearson Education, Inc.
Important topics
• Beta lactam antibiotics
• Tetracyclines
• Antibiotics that disrupt cytoplasmic membrane
• E test, MIC, MBC

More Related Content

What's hot

Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Ravi Kant Agrawal
 
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIRANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
DEVIKA ANTHARJANAM
 
Cell Wall Inhibitors
Cell Wall InhibitorsCell Wall Inhibitors
Cell Wall Inhibitors
shabeel pn
 
Antimicrobial drugs corrected1 300409
Antimicrobial drugs corrected1 300409Antimicrobial drugs corrected1 300409
Antimicrobial drugs corrected1 300409
Kayal Vizhi
 
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
Saminathan Kayarohanam
 
Antibacterials 2
Antibacterials 2Antibacterials 2
Antibacterials 2
pavelbd
 
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Yahya Noori, Ph.D
 
Antimicrobial agents and mechanisms of action 2
Antimicrobial agents and mechanisms of action 2Antimicrobial agents and mechanisms of action 2
Antimicrobial agents and mechanisms of action 2
Bruno Mmassy
 
Chapter 6 antimicrobial drugs
Chapter 6   antimicrobial drugsChapter 6   antimicrobial drugs
Chapter 6 antimicrobial drugs
Alia Najiha
 

What's hot (20)

Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
 
Antimicrobial agents 2 wafaa
Antimicrobial agents 2 wafaaAntimicrobial agents 2 wafaa
Antimicrobial agents 2 wafaa
 
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIRANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
 
Cell Wall Inhibitors
Cell Wall InhibitorsCell Wall Inhibitors
Cell Wall Inhibitors
 
Antimicrobial drugs corrected1 300409
Antimicrobial drugs corrected1 300409Antimicrobial drugs corrected1 300409
Antimicrobial drugs corrected1 300409
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
 
Macrolides by Mohammed Zamir Mirza
Macrolides by  Mohammed Zamir Mirza Macrolides by  Mohammed Zamir Mirza
Macrolides by Mohammed Zamir Mirza
 
Antibacterials 2
Antibacterials 2Antibacterials 2
Antibacterials 2
 
Antimicrobial 3 wafaa
Antimicrobial 3 wafaaAntimicrobial 3 wafaa
Antimicrobial 3 wafaa
 
Antibiotics introduction to classification
Antibiotics introduction to classificationAntibiotics introduction to classification
Antibiotics introduction to classification
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics and their Classification, Beta Lactams
Antibiotics and their Classification, Beta LactamsAntibiotics and their Classification, Beta Lactams
Antibiotics and their Classification, Beta Lactams
 
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
 
Aminoglycoside
AminoglycosideAminoglycoside
Aminoglycoside
 
Beta Lactam Antibiotics
Beta Lactam Antibiotics Beta Lactam Antibiotics
Beta Lactam Antibiotics
 
Antibiotics2008
Antibiotics2008Antibiotics2008
Antibiotics2008
 
Antimicrobial agents and mechanisms of action 2
Antimicrobial agents and mechanisms of action 2Antimicrobial agents and mechanisms of action 2
Antimicrobial agents and mechanisms of action 2
 
Chapter 6 antimicrobial drugs
Chapter 6   antimicrobial drugsChapter 6   antimicrobial drugs
Chapter 6 antimicrobial drugs
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 

Similar to Ch10lecturepresentation 150831183251-lva1-app6892

1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
christomlin11
 
Antibiotics lecture may 2010
Antibiotics lecture may 2010Antibiotics lecture may 2010
Antibiotics lecture may 2010
Bruno Mmassy
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptx
ebulcha100
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
stanbridge
 

Similar to Ch10lecturepresentation 150831183251-lva1-app6892 (20)

Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibacterial chemicals bactericidal and bacteriostatic agents
Antibacterial chemicals bactericidal and bacteriostatic agentsAntibacterial chemicals bactericidal and bacteriostatic agents
Antibacterial chemicals bactericidal and bacteriostatic agents
 
Aminoglycoside
AminoglycosideAminoglycoside
Aminoglycoside
 
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
 
Chemistry of gram negative cell wall with reference to antibiotics
Chemistry of gram negative cell wall with reference to antibioticsChemistry of gram negative cell wall with reference to antibiotics
Chemistry of gram negative cell wall with reference to antibiotics
 
Cell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibioticsCell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibiotics
 
antimicrobialchemotherapy- Mode of action of antibiotics
antimicrobialchemotherapy- Mode of action of antibioticsantimicrobialchemotherapy- Mode of action of antibiotics
antimicrobialchemotherapy- Mode of action of antibiotics
 
Antibiotic (asif) nsupharmacy
Antibiotic (asif) nsupharmacyAntibiotic (asif) nsupharmacy
Antibiotic (asif) nsupharmacy
 
Cell wall inhibitors
Cell wall inhibitorsCell wall inhibitors
Cell wall inhibitors
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Antibiotics lecture may 2010
Antibiotics lecture may 2010Antibiotics lecture may 2010
Antibiotics lecture may 2010
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptx
 
Chemotherapy and Drug Resistance.pptx
Chemotherapy and Drug Resistance.pptxChemotherapy and Drug Resistance.pptx
Chemotherapy and Drug Resistance.pptx
 
Antimicrobial chemotherapy
Antimicrobial chemotherapyAntimicrobial chemotherapy
Antimicrobial chemotherapy
 
Antibacterial agents(1)
Antibacterial agents(1)Antibacterial agents(1)
Antibacterial agents(1)
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistry
 
Lecture 5- antibiotics.ppt
Lecture 5- antibiotics.pptLecture 5- antibiotics.ppt
Lecture 5- antibiotics.ppt
 
lecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentationlecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentation
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 

More from Cleophas Rwemera

More from Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 

Ch10lecturepresentation 150831183251-lva1-app6892

  • 1. © 2015 Pearson Education, Inc. Chapter 10
  • 2. © 2015 Pearson Education, Inc. The History of Antimicrobial Agents • Drugs • Chemicals that affect physiology in any manner • Chemotherapeutic agents • Drugs that act against diseases • Antimicrobial agents • Drugs that treat infections
  • 3. © 2015 Pearson Education, Inc. The History of Antimicrobial Agents • Paul Ehrlich • "Magic bullets" • Arsenic compounds that killed microbes • Alexander Fleming • Penicillin released from Penicillium • Gerhard Domagk • Discovered sulfanilamide • Selman Waksman • Antibiotics • Antimicrobial agents produced naturally by organisms
  • 4. © 2015 Pearson Education, Inc. Figure 10.1 Antibiotic effect of the mold Penicillium chrysogenum. Staphylococcus aureus (bacterium) Zone where bacterial growth is inhibited Penicillium chrysogenum (fungus)
  • 5. © 2015 Pearson Education, Inc. The History of Antimicrobial Agents • Semisynthetics • Chemically altered antibiotics that are more effective, longer lasting, or easier to administer than naturally occurring ones • Synthetics • Antimicrobials that are completely synthesized in a lab
  • 6. © 2015 Pearson Education, Inc.
  • 7. © 2015 Pearson Education, Inc. The History of Antimicrobial Agents • Tell Me Why • Why aren't antibiotics effective against the common cold?
  • 8. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Successful chemotherapy requires selective toxicity • Antibacterial drugs constitute largest number and diversity of antimicrobial agents • Fewer drugs to treat eukaryotic infections • Antiviral drugs limited
  • 9. © 2015 Pearson Education, Inc. Figure 10.2 Mechanisms of action of microbial drugs. Inhibition of cell wall synthesis Penicillins Carbapenems Cephalosporins Vancomycin Bacitracin Isoniazid Ethambutol Echinocandins (antifungal)Inhibition of pathogen’s attachment or entry into host cell Arildone Pleconaril Enfuvirtide Human cell membrane Inhibition of DNA or RNA synthesis Actinomycin Nucleotide analogs Quinolones Rifampin Inhibition of general metabolic pathway Sulfonamides Trimethoprim Dapsone Disruption of cytoplasmic membrane Polymyxins Polyenes (antifungal) Inhibition of protein synthesis Aminoglycosides Tetracyclines Chloramphenicol Macrolides Antisense nucleic acids
  • 10. © 2015 Pearson Education, Inc. Chemotherapeutic Agents: Modes of Action
  • 11. © 2015 Pearson Education, Inc. Figure 10.3a-b Bacterial cell wall synthesis and the inhibitory effects of beta-lactams on it. NAG NAM NAG-NAM chain Crossbridge between NAM and NAM New NAG and NAM subunits Growth A bacterial cell wall is made of peptidoglycan, which is made of NAG-NAM chains that are cross-linked by peptide bridges between the NAM subunits. New NAG and NAM subunits are inserted into the wall by enzymes, allowing the cell to grow. Other enzymes link new NAM subunits to old NAM subunits with peptide cross-links.
  • 12. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Cell Wall Synthesis • Inhibition of synthesis of bacterial walls • Most common agents prevent cross-linkage of NAM subunits • Beta-lactams are most prominent in this group • Functional groups are beta-lactam rings • Beta-lactams bind to enzymes that cross-link NAM subunits • Bacteria have weakened cell walls and eventually lyse
  • 13. © 2015 Pearson Education, Inc. Figure 10.3c-e Bacterial cell wall synthesis and the inhibitory effects of beta-lactams on it. New cross-links inhibited by beta-lactam Previously formed cross-link Penicillins Methicillin (semisynthetic) Carbapenems Imipenem (semisynthetic) Growth Beta-lactam interferes with the linking enzymes, and NAM subunits remain unattached to their neighbors. However, the cell continues to grow as it adds more NAG and NAM subunits. The cell bursts from osmotic pressure because the integrity of peptidoglycan is not maintained. β-lactam ring Penicillin G (natural) Cephalosporins Cephalothin (natural)
  • 14. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Cell Wall Synthesis • Inhibition of synthesis of bacterial walls • Semisynthetic derivatives of beta-lactams • More stable in acidic environments • More readily absorbed • Less susceptible to deactivation • More active against more types of bacteria
  • 15. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Cell Wall Synthesis • Inhibition of synthesis of bacterial walls • Vancomycin and cycloserine • Interfere with particular bridges that link NAM subunits in many Gram-positive bacteria • Bacitracin • Blocks transport of NAG and NAM from cytoplasm • Isoniazid and ethambutol • Disrupt mycolic acid formation in mycobacterial species
  • 16. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Cell Wall Synthesis • Inhibition of synthesis of bacterial walls • Prevent bacteria from increasing amount of peptidoglycan • Have no effect on existing peptidoglycan layer • Effective only for growing cells
  • 17. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Cell Wall Synthesis • Inhibition of synthesis of fungal walls • Fungal cells are composed of various polysaccharides not found in mammalian cells • Echinocandins inhibit the enzyme that synthesizes glucan
  • 18. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Protein Synthesis • Prokaryotic ribosomes are 70S (30S and 50S) • Eukaryotic ribosomes are 80S (40S and 60S) • Drugs can selectively target translation • Mitochondria of animals and humans contain 70S ribosomes • Can be harmful
  • 19. © 2015 Pearson Education, Inc. Figure 10.4 The mechanisms by which antimicrobials target prokaryotic ribosomes to inhibit protein synthesis. Incorrect amino acids Ribosome 30S Some aminoglycosides, for example streptomycin, cause change in 30S shape, so mRNA is misread. 50S Amino acids Chloramphenicol blocks peptide bond formation. 50S Tetracycline and some aminoglycosides block docking site of tRNA. mRNA Lincosamides or macrolides bind to 50S subunit, blocking proper mRNA movement through ribosome. Synthesis stops. fMet Antisense nucleic acid Oxazolidinone30S mRNA mRNA mRNA mRNA mRNA 50S 50S 50S 30S
  • 20. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Disruption of Cytoplasmic Membranes • Some drugs form channel through cytoplasmic membrane and damage its integrity • Amphotericin B attaches to ergosterol in fungal membranes • Humans somewhat susceptible because cholesterol is similar to ergosterol • Bacteria lack sterols; not susceptible
  • 21. © 2015 Pearson Education, Inc. Figure 10.5 Disruption of the cytoplasmic membrane by the antifungal amphotericin B. Amphotericin B Phospholipid Amphotericin B Ergosterol Pore
  • 22. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Disruption of Cytoplasmic Membranes • Azoles and allylamines inhibit ergosterol synthesis • Polymyxin disrupts cytoplasmic membranes of Gram-negative bacteria • Toxic to human kidneys • Pyrazinamide only disrupts transport across the cytoplasmic membrane of Mycobacterium tuberculosis • Some antiparasitic drugs act against cytoplasmic membranes
  • 23. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Metabolic Pathways • Antimetabolic agents can be effective when pathogen and host metabolic processes differ • Atovaquone interferes with electron transport in protozoa and fungi • Heavy metals inactivate enzymes • Agents that disrupt tubulin polymerization and glucose uptake by many protozoa and parasitic worms • Drugs block activation of viruses • Metabolic antagonists
  • 24. © 2015 Pearson Education, Inc. Figure 10.6 The antimetabolic action of sulfonamides in inhibiting nucleic acid synthesis. PABA Sulfanilamide Sulfamethoxazole Sulfisoxazole PABA Enzyme Dihydrofolic acid Enzyme Tetrahydrofolic acid (THF) Enzymes Purine and pyrimidine nucleotides Enzymes DNA and RNA Other substrates PABA Dihydrofolic acid Other substrates PABA Dihydrofolic acid not produced Enzyme Active site Enzyme Para-aminobenzoic acid (PABA) and its structural analogs, the sulfonamides Role of PABA in folic acid synthesis in bacteria and protozoa Inhibition of folic acid synthesis by sulfonamide
  • 25. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Metabolic Pathways • Antiviral agents can target unique aspects of viral metabolism • Amantadine, rimantadine, and weak organic bases prevent viral uncoating • Protease inhibitors interfere with an enzyme that HIV needs in its replication cycle
  • 26. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Nucleic Acid Synthesis • Several drugs block DNA replication or RNA transcription • Drugs often affect both eukaryotic and prokaryotic cells • Not normally used to treat infections • Used primarily in research and perhaps to slow cancer cell replication
  • 27. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Nucleic Acid Synthesis • Nucleotide or nucleoside analogs • Interfere with function of nucleic acids • Distort shapes of nucleic acid molecules and prevent further replication, transcription, or translation • Most often used against viruses • Effective against rapidly dividing cancer cells
  • 28. © 2015 Pearson Education, Inc. Figure 10.7 Nucleosides and some of their antimicrobial analogs.
  • 29. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Inhibition of Nucleic Acid Synthesis • Quinolones and fluoroquinolones • Act against prokaryotic DNA gyrase • Inhibitors of RNA polymerase • Reverse transcriptase inhibitors • Act against an enzyme HIV uses in its replication cycle • Do not harm people because humans lack reverse transcriptase
  • 30. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Prevention of Virus Attachment and Entry • Attachment antagonists block viral attachment or receptor proteins • New area of antimicrobial drug development
  • 31. © 2015 Pearson Education, Inc. Mechanisms of Antimicrobial Action • Tell Me Why • Some antimicrobial drugs are harmful to humans. Why can physicians safely use such drugs despite the potential danger?
  • 32. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Ideal Antimicrobial Agent • Readily available • Inexpensive • Chemically stable • Easily administered • Nontoxic and nonallergenic • Selectively toxic against wide range of pathogens
  • 33. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Spectrum of Action • Number of different pathogens a drug acts against • Narrow-spectrum: effective against few organisms • Broad-spectrum: effective against many organisms • May allow for secondary or superinfections to develop • Killing of normal flora reduces microbial antagonism
  • 34. © 2015 Pearson Education, Inc. Figure 10.8 Spectrum of action for selected antimicrobial agents.
  • 35. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Effectiveness • Efficacy of antimicrobials assessed by a variety of tests • Diffusion susceptibility test • Minimum inhibitory concentration test • Minimum bactericidal concentration test
  • 36. © 2015 Pearson Education, Inc. Figure 10.9 Zones of inhibition in a diffusion susceptibility (Kirby-Bauer) test. Bacterial lawn Zone of inhibition
  • 37. © 2015 Pearson Education, Inc. Figure 10.10 Minimum inhibitory concentration (MIC) test in test tubes. Increasing concentration of drug Turbid wells Clear wells Increasing concentration of drug
  • 38. © 2015 Pearson Education, Inc. Figure 10.11 An Etest, which combines aspects of Kirby-Bauer and MIC tests.
  • 39. © 2015 Pearson Education, Inc. Figure 10.12 A minimum bactericidal concentration (MBC) test. Concentration of antibacterial drug (µg/ml) Clear MIC tube 8 μg/ml 16 μg/ml 25 μg/ml Bacterial colonies No colonies No colonies Drug-free media
  • 40. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Routes of Administration • Topical application of drug for external infections • Oral route requires no needles and is self-administered • Intramuscular administration delivers drug via needle into muscle • Intravenous administration delivers drug directly to bloodstream • Must know how antimicrobial agent will be distributed to infected tissues
  • 41. © 2015 Pearson Education, Inc. Figure 10.13 The effect of route of administration on blood levels of a chemotherapeutic agent.
  • 42. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Safety and Side Effects • Toxicity • Cause of many adverse reactions is poorly understood • Drugs may be toxic to kidneys, liver, or nerves • Consideration needed when prescribing drugs to pregnant women • Therapeutic index is the ratio of the dose of a drug that can be tolerated to the drug's effective dose • Use drug within its therapeutic range
  • 43. © 2015 Pearson Education, Inc. Figure 10.14 Some side effects resulting from toxicity of antimicrobial agents.
  • 44. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Safety and Side Effects • Allergies • Allergic reactions are rare but may be life threatening • Anaphylactic shock • Disruption of normal microbiota • May result in secondary infections • Overgrowth of normal flora, causing superinfections • Of greatest concern for hospitalized patients
  • 45. © 2015 Pearson Education, Inc. Clinical Considerations in Prescribing Antimicrobial Drugs • Tell Me Why • Why don't physicians invariably prescribe the antimicrobial with the largest zone of inhibition?
  • 46. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • The Development of Resistance in Populations • Some pathogens are naturally resistant • Bacteria acquire resistance in two ways • New mutations of chromosomal genes • Acquisition of R plasmids via transformation, transduction, and conjugation.
  • 47. © 2015 Pearson Education, Inc. Figure 10.15 The development of a resistant strain of bacteria. Sensitive cells inhibited by exposure to drug Drug-sensitive cells Drug-resistant mutant Exposure to drug Remaining population grows over time Population of microbial cells Most cells now resistant
  • 48. © 2015 Pearson Education, Inc. Antibiotic Resistance: Origins of Resistance
  • 49. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • Mechanisms of Resistance • At least seven mechanisms of microbial resistance exist • Produce enzyme that destroys or deactivates drug • Slow or prevent entry of drug into the cell • Alter target of drug so it binds less effectively • Alter their own metabolic chemistry • Pump antimicrobial drug out of the cell before it can act • Bacteria in biofilms can resist antimicrobials • Mycobacterium tuberculosis produces MfpA protein • Binds DNA gyrase, preventing the binding of fluoroquinolone drugs
  • 50. © 2015 Pearson Education, Inc. Figure 10.16 How β-lactamase (penicillinase) renders penicillin inactive. Lactam ring Penicillin β-lactamase (penicillinase) breaks this bond Inactive penicillin
  • 51. © 2015 Pearson Education, Inc. Antibiotic Resistance: Forms of Resistance
  • 52. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • Multiple Resistance and Cross Resistance • Pathogen can acquire resistance to more than one drug • Common when R plasmids exchanged • Develop in hospitals and nursing homes • Constant use of drugs eliminates sensitive cells • Multi-drug-resistant pathogens are resistant to at least three antimicrobial agents • Cross resistance to similar drugs may develop
  • 53. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • Retarding Resistance • Maintain high concentration of drug in patient for sufficient time • Inhibit the pathogen so immune system can eliminate • Use antimicrobial agents in combination • Synergism versus antagonism
  • 54. © 2015 Pearson Education, Inc. Figure 10.17 An example of synergism between two antimicrobial agents. Disk with semisynthetic amoxicillin-clavulanic acid Disk with semisynthetic aztreonam
  • 55. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • Retarding Resistance • Use antimicrobials only when necessary • Develop new variations of existing drugs • Second-generation drugs • Third-generation drugs • Search for new antibiotics, semisynthetics, and synthetics • Bacteriocins • Design drugs complementary to the shape of microbial proteins to inhibit them
  • 56. © 2015 Pearson Education, Inc. Resistance to Antimicrobial Drugs • Tell Me Why • Why is it incorrect to say that an individual bacterium develops resistance in response to an antibiotic?
  • 57. © 2015 Pearson Education, Inc. Important topics • Beta lactam antibiotics • Tetracyclines • Antibiotics that disrupt cytoplasmic membrane • E test, MIC, MBC